BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS

Biopharmaceutical Contract Manufacturing Market, By Contract Type (Active Pharmaceutical Ingredient (API) and Fill-And-Finished), By Product Type (Interferon, Monoclonal Antibodies, Protein, Vaccines, Vitamins and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1077
Formats :
Excel and PDF
Industry : Biotechnology

Biopharmaceutical Contract Manufacturing MarketSize and Trends

Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to complexity in manufacturing process of biomolecules, as they consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Contract manufacturing organizations provide services from development of biologics to commercial scale production. Few companies also provide cell line development, fermentation, process optimization, and analytical characterization. Improved efficiency, weak product pipeline, and increasing price pressure is expected to favor the growth of biopharmaceutical contract manufacturing market in near future.

Increasing outsourcing services in biopharmaceutical industry is expected to fuel the growth of biopharmaceutical contract manufacturing market